# SEMAGLUTIDE
> **ANDA220314** · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX INC · Approved 2026-04-07
## Drug
- **FDA Application Number:** ANDA220314
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SEMAGLUTIDE
- **Generic name:** Semaglutide
- **Active ingredients:** SEMAGLUTIDE
- **Dosage form:** INJECTION
- **Route:** SOLUTION
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** APOTEX INC
- **First approval:** 2026-04-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220314)
---
*MORVS · CC0 1.0*